<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940705-2-00192</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=83 g=1 f=1 --> Appendix E&hyph;V.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=3 --> Streptomyces <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Appendix E&hyph;V&hyph;A.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=3 --> Streptomyces <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 -->  Host-Vector 1 Systems  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The following  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Streptomyces <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  species:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Streptomyces coelicolor, S. lividans, S. parvulus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , and  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> S. griseus. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  The following are accepted as vector components of certified  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Streptomyces <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Host-Vector 1 systems:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Streptomyces <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  plasmids SCP2, SLP1.2, pIJ101, actinophage phi C31, and their derivatives.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> Appendix E&hyph;VI. Pseudomonas Putida  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Appendix E&hyph;VI&hyph;A. Pseudomonas putida Host-Vector 1 Systems  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Pseudomonas putida strains <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  KT2440 with plasmid vectors pKT262, pKT263, and pKT264.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Appendix F. Containment Conditions for Cloning of Genes Coding for the Biosynthesis of Molecules Toxic for Vertebrates  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> Appendix F&hyph;I. General Information  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix F specifies the containment to be used for the deliberate cloning of genes coding for the biosynthesis of molecules toxic for vertebrates. The cloning of genes coding for molecules toxic for vertebrates that have an LD <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=2 --> 50 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  of &lt;100 nanograms per kilograms body weight (e.g., microbial toxins such as the botulinum toxins, tetanus toxin, diphtheria toxin,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Shigella dysenteriae <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  neurotoxin) are covered under Section III&hyph;B&hyph;1 and require Institutional Biosafety Committee and NIH/ORDA approval before initiation. No specific restrictions shall apply to the cloning of genes if the protein specified by the gene has an LD <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=2 --> 50 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  "100 micrograms per kilograms of body weight. Experiments involving genes coding for toxin molecules with an LD <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=2 --> 50 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  of &lt;100 micrograms per kilograms and >100 nanograms per kilograms body weight require Institutional Biosafety Committee approval and registration with NIH/ORDA prior to initiating the experiments. A list of toxin molecules classified as to LD <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=2 --> 50 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  is available from NIH/ORDA. Testing procedures for determining toxicity of toxin molecules not on the list are available from the Office of Recombinant DNA Activities, National Institutes of Health, Building 31, Room 4B11, Bethesda, Maryland 20892, (301) 496&hyph;9838. The results of such tests shall be forwarded to NIH/ORDA, which will consult with  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> ad hoc <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  experts, prior to inclusion of the molecules on the list (see Section IV&hyph;C&hyph;1&hyph;b&hyph;(2)&hyph;(e)).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> Appendix F&hyph;II. Cloning of Toxin Molecule Genes in Escherichia coli K&hyph;12  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix F&hyph;II&hyph;A. Cloning of genes coding for molecules toxic for vertebrates that have an LD <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=2 --> 50 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  of >100 nanograms per kilograms and &lt;1000 nanograms per kilograms body weight (e.g., abrin,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Clostridium perfringens  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> epsilon toxin) may proceed under Biosafety Level (BL) 2 + EK2 or BL3 + EK1 containment conditions.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix F&hyph;II&hyph;B. Cloning of genes for the biosynthesis of molecules toxic for vertebrates that have an LD <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=2 --> 50 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  of >1 microgram per kilogram and &lt;100 microgram per kilogram body weight may proceed under BL1 + EK1 containment conditions (e.g.,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Staphylococcus aureus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  alpha toxin,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Staphylococcus aureus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  beta toxin, ricin,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Pseudomonas aeruginosa <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  exotoxin A,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Bordetella pertussis <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  toxin, the lethal factor of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Bacillus anthracis,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Pasteurella pestis  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> murine toxins, the oxygen-labile hemolysins such as streptolysin O, and certain neurotoxins present in snake venoms and other venoms).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix F&hyph;II&hyph;C. Some enterotoxins are substantially more toxic when administered enterally than parenterally. The following enterotoxins shall be subject to BL1 + EK1 containment conditions: cholera toxin, the heat labile toxins of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Escherichia coli, Klebsiella, <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  and other related proteins that may be identified by neutralization with an antiserum monospecific for cholera toxin, and the heat stable toxins of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Escherichia coli <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  and of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Yersinia enterocolitica. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> Appendix F&hyph;III. Cloning of Toxic Molecule Genes in Organisms Other Than Escherichia coli K&hyph;12  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Requests involving the cloning of genes coding for molecules toxic for vertebrates at an LD <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=2 --> 50 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  of &lt;100 nanograms per kilogram body weight in host-vector systems other than  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Escherichia coli  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> K&hyph;12 will be evaluated by NIH/ORDA in consultation with  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> ad hoc  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> toxin experts (see Sections III&hyph;B&hyph;1 and IV&hyph;C&hyph;1&hyph;b&hyph;(2)&hyph;(e)).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> Appendix F&hyph;IV. Specific Approvals  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> An updated list of experiments involving the deliberate formation of recombinant DNA containing genes coding for toxins lethal for vertebrates at an LD <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=2 --> 50 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  of &lt;100 nanograms per kilogram body weight is available from the Office of Recombinant DNA Activities, National Institutes of Health, Building 31, Room 4B11, Bethesda, Maryland 20892, (301) 496&hyph;9838.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Appendix G. Physical Containment  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix G specifies physical containment for standard laboratory experiments and defines Biosafety Level 1 through Biosafety Level 4. For large scale (over 10 liters) research or production, Appendix K supersedes Appendix G. Appendix K defines Good Large Scale Practice through Biosafety Level 3_Large Scale. For certain work with plants, Appendix P supersedes Appendix G. Appendix P defines Biosafety Levels 1 through 4_Plants. For certain work with animals, Appendix Q supersedes Appendix G. Appendix Q defines Biosafety Levels 1 through 4_Animals.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> Appendix G&hyph;I. Standard Practices and Training  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The first principle of containment is strict adherence to good microbiological practices (see Appendices G&hyph;III&hyph;A through G&hyph;III&hyph;J). Consequently, all personnel directly or indirectly involved in experiments using recombinant DNA shall receive adequate instruction (see Sections IV&hyph;B&hyph;1&hyph;e and IV&hyph;B&hyph;4&hyph;d). At a minimum, these instructions include training in aseptic techniques and in the biology of the organisms used in the experiments so that the potential biohazards can be understood and appreciated.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Any research group working with agents that are known or potential biohazards shall have an emergency plan that describes the procedures to be followed if an accident contaminates personnel or the environment. The Principal Investigator shall ensure that everyone in the laboratory is familiar with both the potential hazards of the work and the emergency plan (see Sections IV&hyph;B&hyph;4&hyph;d and IV&hyph;B&hyph;4&hyph;e). If a research group is working with a known pathogen for which there is an effective vaccine, the vaccine should be made available to all workers. Serological monitoring, when clearly appropriate, will be provided (see Section IV&hyph;B&hyph;1&hyph;f).  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            